Dr Finkelstein on the Significance of the 2024 ACRO Summit

Steven E. Finkelstein, MD, DABR, FACRO, chair of Science Education for the American College of Radiation Oncology (ACRO) and a radiation oncologist with the US Oncology Network at Florida Cancer Affiliates, provides insight into the 2024 ACRO Summit, emphasizing its role in advancing education and fostering collaboration among radiation oncologists.

Highlighting the diversity of attendees, including those from academic and community settings, Finkelstein acknowledges that having community-based oncologists attend these types of meetings is crucial, since approximately 80% of patients with cancer are treated in a community setting.

For community oncologists, Finkelstein stresses the necessity of staying up to date on advancements in the rapidly evolving field of radiation oncology. He notes the challenge of managing vast amounts of information and highlights how conferences such as ACRO serve to distill complex concepts into digestible pieces, which are accessible through virtual platforms for those unable to attend in person. Additionally, Finkelstein explains that the cross-pollination of knowledge and networking opportunities offered at ACRO are critical for improving patient care.

Addressing unmet needs in radiation oncology, Finkelstein pinpoints the continued advancement of radiopharmaceuticals as a key area for further development. He emphasizes the importance of collaborative efforts between researchers, clinicians, and industry partners to further develop these therapies and improve patient outcomes in different tumor types.

Finkelstein urges colleagues to actively engage in educational opportunities like the ACRO Summit, emphasizing the importance of continuous learning for delivering high-quality patient care. He also highlights the significance of involving students, trainees, and younger individuals in such endeavors to inspire and shape the future of oncology. Fostering excitement and interest in the field among the next generation of oncologists, Finkelstein concludes.